Penumbra Inc (PEN)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$290.36
Buy
$291.91
$2.115 (+0.73%)
Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.
Prices updated at 08 May 2025, 15:44 BST
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Adam Elsesser
CEO
Mr. Adam Elsesser
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
4,500
Head office
One Penumbra Place
Alameda
United States
94502
Key personnel
Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
---|---|---|---|---|---|
Mr. Harpreet Grewal Independent Director | 0.06m | - | - | 0.24m | - |
Mr. Thomas C. Wilder, III Presiding Independent Director | 0.08m | - | - | 0.26m | - |
Mr. Adam Elsesser Chief Executive Officer, President and Chairman of the Board | 0.63m | - | - | 0.63m | - |
Dr. Arani Bose, M.D. Director | 0.05m | - | - | 0.23m | - |
Ms. Bridget O'Rourke Independent Director | 0.08m | - | - | 0.26m | - |
Ms. Johanna Roberts Executive Vice President, General Counsel and Secretary | 0.70m | - | - | 2.19m | - |
Ms. Janet Leeds Independent Director | 0.07m | - | - | 0.25m | - |
Ms. Surbhi Sarna Independent Director | 0.07m | - | - | 0.25m | - |
Mr. Lambert Shiu Chief Accounting Officer | 0.58m | - | - | 1.56m | - |
Ms. Maggie Yuen Chief Financial Officer | 0.70m | - | - | 1.78m | - |
Top 5 shareholders
Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
---|---|---|---|---|---|---|
FMR Inc | 5,818,874 | 0.08247 | -77522 | -1.314735 | 30 Apr 2025 | 15.03 |
Fidelity Management and Research Company | 5,818,874 | 0.08247 | -77522 | -1.314735 | 30 Apr 2025 | 15.03 |
BlackRock Inc | 4,109,393 | 0.01975 | 40292 | 0.990194 | 30 Apr 2025 | 10.61 |
Vanguard Group Inc | 3,650,622 | 0.0151 | -25683 | -0.698609 | 30 Apr 2025 | 9.43 |
Fidelity SelectCo, LLC | 3,058,726 | 20.75727 | 18582 | - | 30 Apr 2025 | 7.90 |
Director dealings
Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
---|---|---|---|---|---|---|---|
26 Dec 2024 | - | Ms. Johanna Roberts | - | - | 3,798 | - | - |
26 Dec 2024 | - | Ms. Johanna Roberts | 22.04 | 29,754 | 64,000 | - | - |
20 Dec 2024 | - | Mr. Adam Elsesser | 244.75 | 251,848 | 837,582 | - | - |
20 Dec 2024 | - | Mr. Adam Elsesser | 243.91 | 901,979 | 838,611 | - | - |
20 Dec 2024 | - | Mr. Adam Elsesser | 242.94 | 1,320,379 | 842,309 | - | - |
20 Dec 2024 | - | Mr. Adam Elsesser | 240.79 | 192,632 | 851,782 | - | - |
20 Dec 2024 | - | Mr. Adam Elsesser | 242.10 | 977,600 | 847,744 | - | - |
15 Dec 2024 | - | Ms. Johanna Roberts | 245.55 | 194,967 | 62,650 | - | - |
15 Dec 2024 | - | Mr. Lambert Shiu | 245.55 | 73,665 | 24,978 | - | - |
15 Dec 2024 | - | Ms. Maggie Yuen | 245.55 | 147,084 | 14,704 | - | - |
02 Dec 2024 | - | Ms. Johanna Roberts | 243.24 | 25,783 | 63,902 | - | - |
02 Dec 2024 | - | Ms. Johanna Roberts | 245.15 | 68,887 | 63,444 | - | - |
02 Dec 2024 | - | Ms. Johanna Roberts | 244.61 | 43,296 | 63,725 | - | - |
02 Dec 2024 | - | Ms. Johanna Roberts | 242.50 | 8,730 | 64,008 | - | - |
02 Dec 2024 | - | Mr. Lambert Shiu | 243.01 | 158,929 | 20,028 | - | - |
29 Nov 2024 | - | Mr. Lambert Shiu | 242.56 | 436,123 | 20,682 | - | - |
03 Dec 2024 | - | Mr. Lambert Shiu | - | - | - | - | - |
03 Dec 2024 | - | Mr. Lambert Shiu | 12.36 | 64,890 | 25,278 | - | - |
20 Nov 2024 | - | Mr. Adam Elsesser | 236.69 | 1,242,623 | 860,193 | - | - |
20 Nov 2024 | - | Mr. Adam Elsesser | 238.51 | 782,551 | 852,582 | - | - |
Please note that past performance is not a reliable indicator of future returns.